CPC Requests 30-Day Extension for cGMP Guidance Comment Period

The CPC submitted a letter to the FDA docket requesting that the comment period for the Draft Guidance on Current Good Manufacturing Practice Requirements for Combination Products remain open for an additional thirty days in order to give stake holders to adequate time to analyze the complex issues and develop specific, actionable comments.